Advisory Services Network, LLC
Position in ATNM — Actinium Pharmaceuticals, Inc.
CIK 1573876
Atlanta, GA
Position in ATNM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,452
-$2,484 QoQ
Shares Held
1,460
-40.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $24,764,827 across 166 Biotechnology names. ATNM ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
51,990 | $4,893,296 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,953 | $3,054,242 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,218 | $2,330,040 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,314 | $2,089,107 | |
| 5 | RPRX |
Royalty Pharma plc
|
33,855 | $1,624,023 | |
| 6 | EXEL |
Exelixis, Inc.
|
29,442 | $1,262,766 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
138,897 | $1,176,456 | |
| 8 | WVE |
Wave Life Sciences Ltd.
|
144,950 | $1,050,887 |
All Filings in ATNM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,452 | 1,460 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $3,936 | 2,460 | Shares | Sole | 2025-11-18 | |
| 2023-12-31 | $10,769 | 2,120 | Shares | Sole | 2024-02-09 | |
| 2023-03-31 | $14,175 | 1,500 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $10,650 | 1,000 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||